|
Volumn 346, Issue 12, 2011, Pages 1551-1563
|
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease
|
Author keywords
Antigen; Borrelia burgdorferi; Diacylglycerol; Dot blot; Glycolipid; Vaccine
|
Indexed keywords
ACYL GROUP;
ANOMERIC CONFIGURATION;
ANTIGENICITY;
BORRELIA BURGDORFERI;
CAUSATIVE AGENTS;
COMMON VECTORS;
COMPLETE FREUND'S ADJUVANTS;
DIACYLGLYCEROL;
DOT-BLOT;
ETIOLOGICAL AGENT;
GLYCO LIPIDS;
LINOLEIC;
LYME DISEASE;
MYRISTIC ACID;
SYNTHETIC GLYCOLIPIDS;
GLYCEROL;
LINOLEIC ACID;
LIPIDS;
MAMMALS;
PALMITIC ACID;
VACCINES;
ANTIGENS;
1 O ALPHA D GALACTOPYRANOSYL 2,3 DI O PALMITOYL SN GLYCEROL;
1 O ALPHA DEXTRO GALACTOPYRANOSYL 2 O OLEOYL 3 O PALMITOYL SN GLYCEROL;
1 O ALPHA DEXTRO GALACTOPYRANOSYL 2,3 DI O OLEOYL SN GLYCEROL;
1 O ALPHA DEXTRO GALACTOPYRANOSYL 3 O OLEOYL 2 O PALMITOYL SN GLYCEROL;
1,2 DI O ACYL 3 O (ALPHA DEXTRO GALACTOPYRANOSYL) SN GLYCEROL;
3 O (2 O BENZYL ALPHA DEXTRO GALACTOPYRANOSYL) 1,2 O ISOPROPYLIDENE SN GLYCEROL;
3 O (BETA DEXTRO GALACTOPYRANOSYL) 1,2 DI O OLEOYL DEXTRO LEVO GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1 O OLEOYL 2 O PALMITOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1 O OLEOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1 O PALMITOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1,2 DI O OLEOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1,2 DI O PALMITOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 1,2 DI O STEAROYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 2 O OLEOYL 1 O PALMITOYL SN GLYCEROL;
3 O ALPHA DEXTRO GALACTOPYRANOSYL 2 O PALMITOYL 1 O STEAROYL SN GLYCEROL;
3 O BETA DEXTRO GALACTOPYRANOSYL 1,2 DI O OLEOYL SN GLYCEROL;
3 O BETA DEXTRO GALACTOPYRANOSYL 1,2 DI O PALMITOYL SN GLYCEROL;
3,4,6 TRI O BENZOYL 2 O BENZYL ALPHA DEXTRO GALACTOPYRANOSYL;
FREUND ADJUVANT;
GALACTOSE;
GLYCEROL;
GLYCOLIPID;
GLYCOLIPID BBGL 2;
LINOLEIC ACID;
MYRISTIC ACID;
OLEIC ACID;
PALMITIC ACID;
PHENYL 3,4,6 TR O BENZOYL 2 O BENZYL 1 THIO BETA DEXTRO GALACTOPYRANOSIDE;
STEARIC ACID;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ANTIGENICITY;
ARTICLE;
BACTERIAL CELL;
BORRELIA BURGDORFERI;
CHEMICAL STRUCTURE;
CONTROLLED STUDY;
HUMAN;
IMMUNIZATION;
IMMUNOBLOTTING;
MOUSE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
SYNTHESIS;
ANIMALS;
ANTIBODIES, BACTERIAL;
ANTIGENS, BACTERIAL;
BORRELIA BURGDORFERI;
CHROMATOGRAPHY, THIN LAYER;
DIGLYCERIDES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GLYCOLIPIDS;
HUMANS;
IMMUNIZATION;
IMMUNOBLOTTING;
IMMUNODOMINANT EPITOPES;
LYME DISEASE;
MAGNETIC RESONANCE SPECTROSCOPY;
MICE;
MOLECULAR MIMICRY;
OLEIC ACID;
VACCINES, SYNTHETIC;
BORRELIA BURGDORFERI;
MUS;
|
EID: 79960007976
PISSN: 00086215
EISSN: 1873426X
Source Type: Journal
DOI: 10.1016/j.carres.2011.04.045 Document Type: Article |
Times cited : (23)
|
References (41)
|